C
CBAY

Covestor’s Cymabay Therapeutics CBAY Stock Holding History

Covestor’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-9
Closed – – 2890
2023
Q4 		$0 Sell
9
-1
-10% -$18 ﹤0.01% 2862
2023
Q3 		$0 Buy
+10
New +$133 ﹤0.01% 2859

Other funds holding CBAY

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Covestor's CBAY Position: Q1 2024 in Review

Covestor sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 9 shares.

Covestor first reported a position in CBAY in Q3 2023 and held it in 2 quarters. The position peaked at $0 in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

  • Covestor reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Covestor sold 9 Cymabay Therapeutics shares in Q1 2024.
  • Covestor first reported a position in Cymabay Therapeutics in Q3 2023 and held it in 2 quarters.
  • Covestor's Cymabay Therapeutics position peaked at $0 in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Covestor's 13F filing for Q1 2024, filed 10 May 2024.